Aytu Biopharma Inc Stock Ownership - Who owns Aytu Biopharma?

Insider buying vs selling

Have Aytu Biopharma Inc insiders been buying or selling?
Joshua R. DisbrowChief Executive Officer2022-12-19112,371$0.22
Greg PyszczymukaChief Commercial Officer2022-12-19100,000$0.25
Joshua R. DisbrowChief Executive Officer2022-11-18222,000$0.24
Joshua R. DisbrowChief Executive Officer2022-11-18222,000$0.24
Mark K. OkiChief Financial Officer2022-11-1890,000$0.23
Mark K. OkiChief Financial Officer2022-11-1890,000$0.23
Mark K. OkiChief Financial Officer2022-11-1890,000$0.23
Joshua R. DisbrowChief Executive Officer2022-11-18222,000$0.24

1 of 1

AYTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AYTU insiders and whales buy or sell their stock.

AYTU Shareholders

What type of owners hold Aytu Biopharma Inc stock?
Armistice Capital LLC310.05%11,078,956$23.27MInsider
Cerecor Inc271.83%9,713,068$20.40MInsider
James B. Wiegand65.50%2,340,659$4.92MInsider
Renaissance Technologies LLC59.91%2,140,782$4.50MInstitution
Alyeska Investment Group LP41.98%1,500,000$3.15MInstitution
Ampio Pharmaceuticals Inc34.32%1,226,407$2.58MInsider
Millennium Management LLC33.30%1,189,958$2.50MInstitution
Christopher Brooke32.66%1,167,147$2.45MInsider
Joshua R. Disbrow32.24%1,151,877$2.42MInsider
Carl Dockery28.99%1,035,790$2.18MInsider

1 of 3

AYTU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AYTU21.24%78.76%Net Buying
TMBR0.12%99.88%Net Buying

Aytu Biopharma Stock Ownership FAQ

Who owns Aytu Biopharma?

Aytu Biopharma (NASDAQ: AYTU) is owned by 225.38% institutional shareholders, 835.84% Aytu Biopharma insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Aytu Biopharma shareholder, owning 11.08M shares representing 310.05% of the company. Armistice Capital LLC's Aytu Biopharma shares are currently valued at $23.27M.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.